Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
AOD9604 is a modified fragment of human growth hormone, primarily researched for its lipolytic (fat-reducing) properties without promoting cell proliferation or insulin resistance
No removal from Category 2 only ends the prior compounding restriction
In a recent investigation undertaken by our group, adult mice with partial IGF-1 showed a decrease in the expression of genes involved in glucose metabolism (phosphoenolpyruvate carboxylase-1, glucose-6-phosphatase, pyruvate dehydrogenase kinase isoenzyme-4, and ATP-citrate lyase), resulting serious hyperglycaemia [164]
Website could use more research documentation
US$ 25.97
US$ 25.37
US$ 23.48
US$ 22.57
US$ 22.79
US$ 21.54
